Details for Patent: 9,101,615
✉ Email this page to a colleague
Which drugs does patent 9,101,615 protect, and when does it expire?
Patent 9,101,615 protects VARUBI and is included in one NDA.
This patent has twenty-five patent family members in thirteen countries.
Summary for Patent: 9,101,615
| Title: | Intravenous formulations of neurokinin-1 antagonists |
| Abstract: | Pharmaceutical compositions for intravenous administration comprising the compound of Formula I ##STR00001## or pharmaceutically acceptable salts, hydrates or prodrugs thereof are described herein. Methods of preparing the pharmaceutical compositions and methods for treating nausea and/or emesis with the pharmaceutical compositions are also described herein. |
| Inventor(s): | Wan; Jiansheng (Warren, NJ), Gupta; Pranav (Short Hills, NJ), Monteith; David (Pittstown, NJ), Bhattacharya; Soumendu (East Windsor, NJ) |
| Assignee: | OPKO Health, Inc. (Miami, FL) |
| Application Number: | 12/855,889 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 9,101,615
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tersera | VARUBI | rolapitant hydrochloride | EMULSION;INTRAVENOUS | 208399-001 | Oct 25, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | PREVENTION OF DELAYED NAUSEA AND VOMITING ASSOCIATED WITH EMETOGENIC CANCER CHEMOTHERAPY | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,101,615
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2010282483 | ⤷ Sign Up | |||
| Brazil | 112012003263 | ⤷ Sign Up | |||
| Canada | 2770403 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
